Author: sHq_LoGiNz
PITTSBURGH, Oct. 12, 2025 /PRNewswire/ — Duquesne University President Ken Gormley has announced that Jim and Celeste Nasuti have made a transformational gift to Duquesne for its College of Osteopathic Medicine. The medical school will now be named the Nasuti College of Osteopathic Medicine, in recognition of the Nasuti family providing Duquesne one of the two largest philanthropic commitments in its history.
Gormley announced the gift during the University’s Homecoming celebrations. The gift from the Nasuti family is the second largest gift commitment in Duquesne’s nearly 150-year history. The University is honoring the family’s request to keep the precise amount of the gift confidential, instead celebrating its impact on future medical students and on Duquesne’s ability to become a leader in health care education, which is the family’s principal focus.
“To have a couple with such meaningful connections to Duquesne and Pittsburgh emerge and provide such transformational philanthropic support for our medical school is truly inspirational,” said Gormley. “A significant portion of the funding will be used for scholarships, so that students who want to attend this mission-focused medical school will have that opportunity. This will enable our highly trained graduates of the Nasuti College of Osteopathic Medicine to go on and serve others in myriad ways.”
Jim Nasuti, a 1970 Duquesne graduate, and Celeste Bahl Nasuti, a Pittsburgh native, are co-founders of Summerwood, a Conshohocken, Pa.-based company that operates more than 200 Taco Bell and KFC franchises across six states. Their gift will support scholarships and faculty development, helping to ensure access to medical education for aspiring physicians committed to service.
“We are just honored to be associated with such an excellent project,” said Jim Nasuti. “The world needs doctors. Plus, Duquesne adds that important consideration of service and helping people, going back to its founding purpose to help immigrants to Pittsburgh.”
Celeste Nasuti added, “This is a family decision and a family commitment. Our children are involved in our business and in this gift. We believe in Duquesne’s mission and its people.”
The connection of the Nasuti family to Duquesne runs deep. Jim attended Duquesne after graduating from Holy Ghost Preparatory School, a sister Spiritan institution in the suburbs of Philadelphia. Celeste’s family has longstanding ties to Duquesne, including her late parents. Both her father and mother were Duquesne students in the 1930s, and her father also graduated from Duquesne Prep.
“The Nasutis’ care for people aligns with our Spiritan commitment to developing authentic relationships,” said the Rev. John Fogarty, C.S.Sp., U.S. Provincial of the Spiritans. “It’s wonderful to have people that have modeled that work serve as benefactors for the school, and to see a connection all the way from Holy Ghost Prep to Duquesne to now!”
Diane Hupp, Chair of Duquesne’s Board of Directors and CEO of UPMC Children’s Hospital, emphasized the societal impact of the gift: “We need highly qualified doctors, especially primary care doctors, and their gift is serving a crucial good for our society. We are honored to be the home of the Nasuti College of Osteopathic Medicine at this special university.”
View original content to download multimedia:https://www.prnewswire.com/news-releases/duquesne-university-names-medical-school-in-honor-of-transformational-donation-from-nasuti-family-302581406.html
SOURCE Duquesne University
CHICAGO, Oct. 11, 2025 /PRNewswire/ — After one week of pre-trial motions, on October 7, 2025, Cook County Law Division Judge Preston Jones, Jr., approved a settlement of $8,600,000.00 for the benefit of a 9-year-old boy who Plaintiffs alleged suffered a brain injury secondary to hypoxic ischemic encephalopathy (HIE) during birth at an undisclosed Chicago area hospital. Plaintiffs alleged the birth injury occurred when the mother’s OB/GYN and hospital nurses failed to properly monitor the labor and delivery and failed to perform a timely delivery by C-section and failed to have a clean operating room available when the C-section was indicated resulting in the procedure being further delayed.
On April 4, 2016, the child’s mother presented to the hospital experiencing severe back pain and was scheduled for induction later that day. The mother labored without complication for approximately 13 hours, and then fetal heart tracings deteriorated over the next 2.5 hours when the mother was instructed to push. The need for urgent delivery with forceps was discussed, but unavailable because of the lack of fetal descent. Thereafter, the physician determined that C-section delivery would proceed in 20 minutes if no change and Plaintiffs alleged that hospital policy dictated that an emergency cesarian section be performed. Despite instruction and hospital policy, C-section was not performed for another 90 minutes. Plaintiffs alleged that the C-section was delayed because of a lack of clean operating rooms and an apparent unavailability of operating room staff.
When the baby was born, the umbilical cord was wrapped around his neck three times. He was limp, not breathing, had low Apgar scores, and cord blood gases revealed severe metabolic acidosis. The diagnosis of HIE was ultimately given and by the age of two, significant neurodevelopmental delays were identified.
Counsel for the undisclosed hospital maintained that the child did not suffer a brain injury secondary to HIE caused by the nuchal cord, that there was no need for a delivery by emergency cesarean section and that the lack of clean operating rooms and under staffing did not delay the delivery by cesarean section being performed.
Attorneys for the estate of the child, Donald J. Nolan, Timothy I McArdle and Thomas P. Routh of Nolan Law Group alleged that the OB/GYN and nurses’ failure to properly monitor the delivery and the hospital’s failure to have an operating room available to perform an emergent delivery by C-section resulted in a brain injury. Summary judgment was previously entered in the case finding that the mother’s obstetrician was an agent of the Hospital.
Nolan Law Group is a Chicago based personal injury law firm concentrating in cases involving aviation accidents, brain injury, medical malpractice, product liability, and construction negligence.
|
CASE NUMBER: |
Subject To Confidentiality Agreement |
|
JUDGE: |
The Honorable Preston Jones, Jr. |
|
Gross Settlement: |
$8,600,000.00 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/8-6-million-dollar-settlement-approved-for-9-year-old-boy-represented-by-nolan-law-group-paid-by-undisclosed-chicago-area-hospital-for-birth-injury-302581381.html
SOURCE Nolan Law Group
- Lucid Gravity Grand Touring starts at $134,5001 CDN and is available to order now
- Lucid Gravity delivers an interior with space for up to 7-adults and their gear
- Lucid Gravity offers up to nearly 3,400 litres of cargo space.
- The full Lucid Gravity product line features an integrated NACS charging port and access to the Tesla Supercharger network, with Gravity Grand Touring projected to have up to 720km2 of range and 400 kW fast charging.
TORONTO, ON, Oct. 11, 2025 /PRNewswire/ — Lucid Group, Inc. (NASDAQ: LCID), maker of the world’s most advanced electric vehicles, today announced that deliveries of the Lucid Gravity have begun in Canada.
“There has been great anticipation for the Lucid Gravity in Canada,” said Erwin Raphael, Vice President of Revenue at Lucid Group. “It offers space for up to seven adults and their luggage. It can handle even the most challenging conditions, making it ideal for extended road trips.”
The Lucid Gravity Grand Touring is equipped with dual electric motors delivering 828 horsepower and can accelerate from 0-100km in 3.6 seconds, while delivering over 720km3 of projected range on a single charge. As with its award-winning Air sedan, Lucid leveraged its innovative Space Concept philosophy to deliver an expansive interior that comfortably seats up to seven adults with space remaining for their luggage. It can also offer up to nearly 3,400 litres of cargo space.
Lucid Gravity offers wide access, with no adapter necessary to the Tesla Supercharger network. Groundbreaking technology will allow the 926V Lucid Gravity Grand Touring to charge seamlessly at up to 400kW on 1000V charging equipment and at sustained speeds of up to 225kW on 500V architecture fast chargers, including Tesla V3 Superchargers. At peak charging rates, the Lucid Gravity sustains a robust charging curve, adding more than 320 kms in less than 11 minutes.
Customers in Canada can create their own Lucid Gravity Grand Touring on the “Design Yours” configurator on the Lucid website, links to which can be found here for English and here for French. Conceived from the ground up without compromise, Lucid Gravity is enabled by Lucid’s revolutionary technology to provide the interior space and practicality of a full-size SUV within the exterior footprint of a mid-size SUV. As a result, it provides a sophisticated space for up to seven adults, game-changing versatility, and an unparalleled driving experience.
Lucid’s global network includes 64 Studios and Service Centers, you can find the nearest location at https://lucidmotors.com/locations.
About Lucid Group
Lucid (NASDAQ: LCID) is a Silicon Valley-based technology company focused on creating the most advanced EVs in the world. The award-winning Lucid Air and new Lucid Gravity deliver best-in-class performance, sophisticated design, expansive interior space and unrivaled energy efficiency. Lucid assembles both vehicles in its state-of-the-art, vertically integrated factory in Arizona. Through its industry-leading technology and innovations, Lucid is advancing the state-of-the-art of EV technology for the benefit of all.
Media Contact
media@lucidmotors.com
|
|
|
|
|
|
View original content to download multimedia:https://www.prnewswire.com/news-releases/lucid-gravity-grand-touring-customer-deliveries-begin-in-canada-302581364.html
SOURCE Lucid Group
New Montefiore Einstein Research Published in The Lancet Respiratory Medicine Emphasizes Importance of Multi-Faceted, Symptom-Focused Treatment Strategy for Critically Ill Patients
BRONX, N.Y., Oct. 11, 2025 /PRNewswire/ — In the U.S., more than 5 million people are admitted to Intensive Care Units (ICUs) each year for the treatment of acute or life-threatening medical problems. Mechanical ventilation, when a machine moves air into and out of the lungs of people experiencing acute respiratory distress, is a crucial form of life support provided to more than 300,000 patients annually in the ICU. New research published in The Lancet Respiratory Medicine shows that in a cohort of more than 10,000 people, patients who received a high proportion of deep sedation while mechanically ventilated had a greater risk of adverse discharge – losing their ability to live independently – compared to patients who did not receive deep sedation.
Good Intentions Lead to Unintended Harm
Deep sedation – when medications keep patients from being fully conscious and not easily aroused – is commonly used in ICUs across the country with the aim of preventing ventilated patients from experiencing emotional distress and/or pain during their critical recovery. Since the COVID-19 pandemic, the use of deep sedation has become more common practice in ICUs nationwide. The problem is that when a patient is deeply sedated, it inhibits them from being able to move their bodies, causing unintended harm. Findings from investigators in the Department of Anesthesiology at Montefiore Einstein suggest that patients who received targeted, symptom-focused treatments with non-opioid medications, instead of deep sedation, had higher rates of independent living after being discharged from the hospital.
“In this study, we found sedative medications were more likely to be delivered to patients to aid with sleep and rest, however use of sedative medications can actually strip the exhausted patient of the healthy restorative sleep they need most during illness,” said author Matthias Eikermann M.D., Francis F. Foldes Professor and Chair, Department of Anesthesiology at Montefiore Einstein. “Our data shows this lack of quality sleep leads to greater rates of immobility in the ICU, which compounds into even more delirium and greater loss of the muscles and nerves needed during recovery.”
With evidence from this study, the Department of Anesthesiology spearheaded the creation of a system-wide Mobilization Committee including the departments of Anesthesiology, Medicine, and Rehabilitation Medicine (including physical therapy, and respiratory therapy teams) and nursing, with the goal of reducing the use of deep sedation and increasing early mobilization in the ICUs. This multidisciplinary group will conduct targeted rounds in the ICUs to identify barriers to early mobilization and develop strategies to implement patient-centered interventions. Efforts are supported by a digital patient board in Montefiore Einstein’s electronic record system to track these newly developed protocols and a new Surgical ICU Order Set to ensure clinicians have the tools needed to identify alternative pain treatments.
By deploying a new symptom-focused treatment strategy, Montefiore Einstein investigators believe that providers will be able to more comprehensively evaluate patients and recognize symptoms of emotional distress, treating them accordingly with antipsychotics or non-opioid analgesics.
“Our hope is that the data published in this investigation will fuel national efforts to improve education about deep sedation and adherence to evidence-based guidelines,” said Dr. Eikermann. “The ultimate goal is to enhance overall patient care and help people return to the lives they want to live with their loved ones.”
About Montefiore Health System
Montefiore Health System is one of New York’s premier academic health systems. It is a recognized leader in providing exceptional quality and personalized, accountable care to approximately three million people in communities across the Bronx, Westchester, and the Hudson Valley. It comprises ten hospitals, including the Children’s Hospital at Montefiore, Burke Rehabilitation Hospital, and over two hundred outpatient ambulatory care sites. The advanced clinical and translational research at its medical school, Albert Einstein College of Medicine, directly informs patient care and improves outcomes. From the Montefiore-Einstein Centers of Excellence in cancer, cardiology and vascular care, pediatrics, and transplantation, to its preeminent school-based health program, Montefiore is a fully integrated healthcare delivery system providing coordinated, comprehensive care to patients and their families. For more information, please visit www.montefiore.org. Follow us on Twitter, Instagram, and LinkedIn, or view us on Facebook and YouTube
About Albert Einstein College of Medicine
Albert Einstein College of Medicine is one of the nation’s premier centers for research, medical education and clinical investigation. During the 2024-25 academic year, Einstein is home to 712 M.D. students, 226 Ph.D. students, 112 students in the combined M.D./Ph.D. program, and approximately 250 postdoctoral research fellows. The College of Medicine has more than 2,000 full-time faculty members located on the main campus and at its clinical affiliates. In 2024, Einstein received more than $192 million in awards from the National Institutes of Health. This includes the funding of major research centers at Einstein in cancer, aging, intellectual development disorders, diabetes, clinical and translational research, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Its partnership with Montefiore, the University Hospital and academic medical center for Einstein, advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. For more information, please visit einsteinmed.edu, follow us on Twitter, Facebook, Instagram, LinkedIn, and view us on YouTube.
View original content to download multimedia:https://www.prnewswire.com/news-releases/people-who-receive-less-sedation-when-ventilator-dependent-more-likely-to-return-to-independent-living-after-hospitalization-302580113.html
SOURCE Montefiore Health System
New Montefiore Einstein Research Published in The Lancet Respiratory Medicine Emphasizes Importance of Multi-Faceted, Symptom-Focused Treatment Strategy for Critically Ill Patients
BRONX, N.Y., Oct. 11, 2025 /PRNewswire/ — In the U.S., more than 5 million people are admitted to Intensive Care Units (ICUs) each year for the treatment of acute or life-threatening medical problems. Mechanical ventilation, when a machine moves air into and out of the lungs of people experiencing acute respiratory distress, is a crucial form of life support provided to more than 300,000 patients annually in the ICU. New research published in The Lancet Respiratory Medicine shows that in a cohort of more than 10,000 people, patients who received a high proportion of deep sedation while mechanically ventilated had a greater risk of adverse discharge – losing their ability to live independently – compared to patients who did not receive deep sedation.
Good Intentions Lead to Unintended Harm
Deep sedation – when medications keep patients from being fully conscious and not easily aroused – is commonly used in ICUs across the country with the aim of preventing ventilated patients from experiencing emotional distress and/or pain during their critical recovery. Since the COVID-19 pandemic, the use of deep sedation has become more common practice in ICUs nationwide. The problem is that when a patient is deeply sedated, it inhibits them from being able to move their bodies, causing unintended harm. Findings from investigators in the Department of Anesthesiology at Montefiore Einstein suggest that patients who received targeted, symptom-focused treatments with non-opioid medications, instead of deep sedation, had higher rates of independent living after being discharged from the hospital.
“In this study, we found sedative medications were more likely to be delivered to patients to aid with sleep and rest, however use of sedative medications can actually strip the exhausted patient of the healthy restorative sleep they need most during illness,” said author Matthias Eikermann M.D., Francis F. Foldes Professor and Chair, Department of Anesthesiology at Montefiore Einstein. “Our data shows this lack of quality sleep leads to greater rates of immobility in the ICU, which compounds into even more delirium and greater loss of the muscles and nerves needed during recovery.”
With evidence from this study, the Department of Anesthesiology spearheaded the creation of a system-wide Mobilization Committee including the departments of Anesthesiology, Medicine, and Rehabilitation Medicine (including physical therapy, and respiratory therapy teams) and nursing, with the goal of reducing the use of deep sedation and increasing early mobilization in the ICUs. This multidisciplinary group will conduct targeted rounds in the ICUs to identify barriers to early mobilization and develop strategies to implement patient-centered interventions. Efforts are supported by a digital patient board in Montefiore Einstein’s electronic record system to track these newly developed protocols and a new Surgical ICU Order Set to ensure clinicians have the tools needed to identify alternative pain treatments.
By deploying a new symptom-focused treatment strategy, Montefiore Einstein investigators believe that providers will be able to more comprehensively evaluate patients and recognize symptoms of emotional distress, treating them accordingly with antipsychotics or non-opioid analgesics.
“Our hope is that the data published in this investigation will fuel national efforts to improve education about deep sedation and adherence to evidence-based guidelines,” said Dr. Eikermann. “The ultimate goal is to enhance overall patient care and help people return to the lives they want to live with their loved ones.”
About Montefiore Health System
Montefiore Health System is one of New York’s premier academic health systems. It is a recognized leader in providing exceptional quality and personalized, accountable care to approximately three million people in communities across the Bronx, Westchester, and the Hudson Valley. It comprises ten hospitals, including the Children’s Hospital at Montefiore, Burke Rehabilitation Hospital, and over two hundred outpatient ambulatory care sites. The advanced clinical and translational research at its medical school, Albert Einstein College of Medicine, directly informs patient care and improves outcomes. From the Montefiore-Einstein Centers of Excellence in cancer, cardiology and vascular care, pediatrics, and transplantation, to its preeminent school-based health program, Montefiore is a fully integrated healthcare delivery system providing coordinated, comprehensive care to patients and their families. For more information, please visit www.montefiore.org. Follow us on Twitter, Instagram, and LinkedIn, or view us on Facebook and YouTube
About Albert Einstein College of Medicine
Albert Einstein College of Medicine is one of the nation’s premier centers for research, medical education and clinical investigation. During the 2024-25 academic year, Einstein is home to 712 M.D. students, 226 Ph.D. students, 112 students in the combined M.D./Ph.D. program, and approximately 250 postdoctoral research fellows. The College of Medicine has more than 2,000 full-time faculty members located on the main campus and at its clinical affiliates. In 2024, Einstein received more than $192 million in awards from the National Institutes of Health. This includes the funding of major research centers at Einstein in cancer, aging, intellectual development disorders, diabetes, clinical and translational research, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Its partnership with Montefiore, the University Hospital and academic medical center for Einstein, advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. For more information, please visit einsteinmed.edu, follow us on Twitter, Facebook, Instagram, LinkedIn, and view us on YouTube.
View original content to download multimedia:https://www.prnewswire.com/news-releases/people-who-receive-less-sedation-when-ventilator-dependent-more-likely-to-return-to-independent-living-after-hospitalization-302580113.html
SOURCE Montefiore Health System